Analysts think NNVC stock price could increase by 418.75%
May 12, 2025, 11:04 AM
-44.92%
What does NNVC do
NanoViricides, based in Shelton, Connecticut, develops nanomedicine drugs targeting enveloped viruses, with lead candidates NV-CoV-2 for COVID-19 and NV-HHV-1 for Shingles. The company went public on August 12, 2004.
As of May 12, 2025, three analysts have issued price targets for NanoViricides (NNVC), with a median target of $6.63 — representing a potential 418.75% upside from the current price of $1.28. Analyst estimates range from $6.57 to $6.83.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.